Acadia Healthcare Company, Inc. (ACHC) Cash Flow Statement

The OCF/NI ratio of 14.83 in Q2 2026 is extreme, reflecting the $1.2B non-cash charge in Q4 2025 that depressed net income while operating cash flow remained positive. This suggests that the company's underlying cash earnings power is significantly stronger than GAAP net income implies, but investors should monitor whether legal settlements will continue to distort reported profitability. The gap between net income and operating cash flow is primarily driven by large non-cash accruals, not by operational deterioration.

The positive FCF in Q2 2026 is a notable reversal from the negative FCF of the prior five quarters, driven by a sharp reduction in capital expenditures and a favorable working capital swing. However, the trajectory remains highly volatile, with FCF margins ranging from -60.4% to 27.6% over the past ten quarters, suggesting that the company's cash generation is not yet stable. This volatility may reflect lumpy legal settlements and timing of capex, warranting caution in extrapolating the latest quarter's performance.

The dramatic reduction in capital intensity suggests that management is prioritizing cash conservation over aggressive bed expansion, possibly in response to labor shortages and litigation costs. While this may improve near-term FCF, it could limit future revenue growth if the company cannot staff existing beds or open new facilities. Investors should monitor whether this capex reduction is temporary or reflects a strategic pivot away from the de novo growth model.

The extreme volatility in working capital, particularly the -$459.5M swing in Q1 2024, suggests that the company's cash flow is heavily influenced by timing of collections and payables, possibly related to government reimbursement programs. The positive working capital contribution in Q2 2026 may indicate improved collections or delayed payments, but such swings are not sustainable and could reverse. This volatility complicates the assessment of underlying operational cash generation.

The company appears to be retaining all cash flow to fund operations and potential acquisitions, with no shareholder returns via dividends or meaningful buybacks. The modest acquisition activity in recent quarters suggests a cautious approach to M&A, possibly due to balance sheet constraints or a focus on integrating existing JVs. Investors seeking income or capital return should note the absence of such programs, which may continue given the need to preserve liquidity.

The cumulative gap between net income and operating cash flow is driven by the $1.2B non-cash charge in Q4 2025, which depressed net income but did not affect cash flow. This suggests that the company's cash-generating ability is far stronger than GAAP earnings indicate, but the persistence of such charges raises questions about the quality of reported earnings. Investors should adjust for these non-recurring items to assess the true cash earnings power of the business.